Filing Flows › Sanofi (SNY) › Gross margin
Sanofi (SNY) gross margin by quarter
Sanofi's gross margin was 80.3% in Q3 2026 (third quarter 2026), +0.3 pts from Q2 2026. Over the last 5 quarters it ranged from 77.1% (Q1 2026) to 80.3% (Q3 2026).
| Quarter | Gross margin | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | 80.3% | +0.3 pts | +1.8 pts |
| Q2 2026 | 80.0% | +2.9 pts | +2.6 pts |
| Q1 2026 | 77.1% | -1.3 pts | — |
| Q3 2025 | 78.5% | +1.0 pts | — |
| Q2 2025 | 77.5% | — | — |
Q3 2026 at a glance
Sanofi, Q3 2026: revenue $14.4B (+16% year over year), operating margin 30.1%, net earnings $3.0B, operating cash flow $3.9B. The chart follows the revenue to costs, profit and cash.
Questions
What is Sanofi's gross margin?
Sanofi's gross margin was 80.3% in Q3 2026 (third quarter 2026), +0.3 pts from Q2 2026.
How has Sanofi's gross margin changed?
Over the last 5 quarters it ranged from 77.1% (Q1 2026) to 80.3% (Q3 2026).